Trial Profile

Efficacy of liraglutide QD vs. sitagliptin QD vs. insulin glargine on liver fat when combined with metformin in T2DM subjects with NAFLD

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 07 Sep 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Liraglutide (Primary) ; Insulin glargine; Metformin; Sitagliptin
Indications Non-alcoholic fatty liver disease; Type 2 diabetes mellitus
Focus Therapeutic Use

Most Recent Events

28 Aug 2016 Status changed from not yet recruiting to completed.
02 Jul 2014 New trial record
21 May 2014 Planned End Date changed from 1 Apr 2016 to 1 Mar 2016 as reported by Chinese Clinical Trial Register.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com